Shuji Mikami

Publication Activity (10 Years)

Years Active: 2015-2022
Publications (10 Years): 9

Top Topics

Renal Cell Carcinoma

Ejection Fraction

Tyrosine Kinase

Top Venues

International journal of molecular sciences

Pathology international

International journal of endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Keisuke Shigeta, Kazuhiro Matsumoto, Nobuyuki Tanaka, Shuji Mikami, Takeo Kosaka, Yota Yasumizu, Toshikazu Takeda, Ryuichi Mizuno, Eiji Kikuchi, Mototsugu Oya
Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma. International journal of molecular sciences 23 (9) (2022)
Arisa Ueki, Kokichi Sugano, Kumiko Misu, Eriko Aimono, Kohei Nakamura, Shigeki Tanishima, Nobuyuki Tanaka, Shuji Mikami, Akira Hirasawa, Miho Ando, Teruhiko Yoshida, Mototsugu Oya, Hiroshi Nishihara, Kenjiro Kosaki
Germline Whole-Gene Deletion of FH Diagnosed from Tumor Profiling. International journal of molecular sciences 22 (15) (2021)
Kazuhiro Matsumoto, Kazuhiro Matsumoto, Koichiro Ogihara, Tetsushi Murakami, Tadatsugu Anno, Kota Umeda, Mizuki Izawa, Yuto Baba, Tansei Sanjo, Kazunori Shojo, Nobuyuki Tanaka, Toshikazu Takeda, Takeo Kosaka, Ryuichi Mizuno, Shuji Mikami, Takeo Kosaka, Mototsugu Oya
The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma. Cancer science 112 (3) (2021)
Kazuhiro Matsumoto, Masanori Hasegawa, Takeo Kosaka, Yota Yasumizu, Takeo Kosaka, Ryuichi Mizuno, Shuji Mikami, Akira Miyajima, Donald Kufe, Mototsugu Oya
Role of the MUC1-C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma. Cancer science 111 (10) (2020)
Yoshinori Yanai, Takeo Kosaka, Kohei Nakamura, Eriko Aimono, Kazuhiro Matsumoto, Shinya Morita, Shuji Mikami, Hiroshi Nishihara, Mototsugu Oya
CDK12 and HER2 coamplification in two urothelial carcinomas with rapid and aggressive clinical progression. Cancer science 111 (12) (2020)
Shuji Mikami, Ryuichi Mizuno, Takeo Kosaka, Nobuyuki Tanaka, Naoto Kuroda, Yoji Nagashima, Yasunori Okada, Mototsugu Oya
Significance of tumor microenvironment in acquiring resistance to vascular endothelial growth factor-tyrosine kinase inhibitor and recent advance of systemic treatment of clear cell renal cell carcinoma. Pathology international 70 (10) (2020)
Shuji Mikami, Ryuichi Mizuno, Tsunenori Kondo, Nobuo Shinohara, Norio Nonomura, Seiichiro Ozono, Masatoshi Eto, Katsunori Tatsugami, Tatsuya Takayama, Hideyasu Matsuyama, Takeshi Kishida, Mototsugu Oya, null null
Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma. Cancer science 110 (6) (2019)
Nishimoto Koshiro, Tsugio Seki, Yuichiro Hayashi, Shuji Mikami, Ghaith Al-Eyd, Ken Nakagawa, Shinya Morita, Takeo Kosaka, Mototsugu Oya, Fumiko Mitani, Makoto Suematsu, Yasuaki Kabe, Kuniaki Mukai
Human Adrenocortical Remodeling Leading to Aldosterone-Producing Cell Cluster Generation. International journal of endocrinology 2016 (2016)
Ryo Ogawa, Tomohiro Hikata, Shuji Mikami, Nobuyuki Fujita, Akio Iwanami, Kota Watanabe, Ken Ishii, Masaya Nakamura, Yoshiaki Toyama, Morio Matsumoto
Total en bloc spondylectomy for locally aggressive vertebral hemangioma causing neurological deficits. Case reports in orthopedics 2015 (2015)